BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 16524062)

  • 1. [Malignant neoplasias in renal transplantation recipients].
    Gómez-Roel X; León-Rodríguez E
    Rev Invest Clin; 2005; 57(2):225-9. PubMed ID: 16524062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Solid tumors after kidney transplantation].
    Moal MC
    Nephrol Ther; 2008 Oct; 4 Suppl 3():S214-7. PubMed ID: 19000890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer incidence in 854 kidney transplant recipients from a single institution: comparison with normal population and with patients under dialytic treatment.
    Montagnino G; Lorca E; Tarantino A; Bencini P; Aroldi A; Cesana B; Braga M; Lonati F; Ponticelli C
    Clin Transplant; 1996 Oct; 10(5):461-9. PubMed ID: 8930463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conversion to rapamycin immunosuppression for malignancy after kidney transplantation: case reports.
    Iaria G; Anselmo A; De Luca L; Manuelli M; Lucchesi C; Tariciotti L; Monaco A; Sforza D; Nigro F; Abruzzese E; Tisone G
    Transplant Proc; 2007; 39(6):2036-7. PubMed ID: 17692685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is there a role for proliferation signal/mTOR inhibitors in the prevention and treatment of de novo malignancies after heart transplantation? Lessons learned from renal transplantation and oncology.
    Valantine H
    J Heart Lung Transplant; 2007 Jun; 26(6):557-64. PubMed ID: 17543777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urological malignancy after renal transplantation.
    Besarani D; Cranston D
    BJU Int; 2007 Sep; 100(3):502-5. PubMed ID: 17669141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronologically different incidences of post-transplant malignancies in renal transplant recipients: single center experience.
    Ju MK; Joo DJ; Kim SJ; Huh KH; Kim MS; Jeon KO; Kim HJ; Kim SI; Kim YS
    Transpl Int; 2009 Jun; 22(6):644-53. PubMed ID: 19220824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early de novo malignancies after kidney transplantation.
    Veroux M; Puliatti C; Fiamingo P; Cappello D; Macarone M; Puliatti D; Vizcarra D; Gagliano M; Veroux P
    Transplant Proc; 2004 Apr; 36(3):718-20. PubMed ID: 15110643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urological malignancy as a complication of renal transplantation: a report of twelve clinical cases.
    Zhou M; Zhu Y; Wang L; Wang Y; Fu S; Min Z
    Clin Transpl; 2006; ():395-8. PubMed ID: 18365395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pro and anti-neoplastic effects of immunosuppressive drug in renal transplantation].
    Infante B; Stallone G; Schena A; Maiorano A; Gesualdo L; Schena FP; Grandaliano G
    G Ital Nefrol; 2006; 23(4):389-95. PubMed ID: 17063439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [De novo malignant tumors during drug immunosuppression. The findings following 1245 cadaveric kidney transplants in 1080 patients].
    Walz MK; Albrecht KH; Niebel W; Eigler FW
    Dtsch Med Wochenschr; 1992 Jun; 117(24):927-34. PubMed ID: 1600867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Malignancy after renal transplantation.
    Zeier M; Hartschuh W; Wiesel M; Lehnert T; Ritz E
    Am J Kidney Dis; 2002 Jan; 39(1):E5. PubMed ID: 11774131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Malignancies in organ transplant recipients.
    Hoshida Y; Aozasa K
    Pathol Int; 2004 Sep; 54(9):649-58. PubMed ID: 15363032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Skin malignancies in renal transplant recipients: a Brazilian center registry.
    Falsarella PM; Alves-Filho G; Mazzali M
    Transplant Proc; 2008 Apr; 40(3):767-8. PubMed ID: 18455011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of malignancy following living donor kidney transplantation.
    Nafar M; Einollahi B; Hemati K; Gholi FP; Firouzan A
    Transplant Proc; 2005 Sep; 37(7):3065-7. PubMed ID: 16213306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Occurrence of cancers in immunosuppressed organ transplant recipients.
    Penn I
    Clin Transpl; 1994; ():99-109. PubMed ID: 7547597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of oropharyngeal cancer in renal transplant recipients without cessation of immunosuppressive therapy.
    Singh SK; Gupta AK; Jha V; Kohli HS; Gupta KL; Minz M; Sakhuja V
    Transplant Proc; 2006 Sep; 38(7):2088-9. PubMed ID: 16980008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Malignancies after kidney transplantation.
    Rascente M; Pisani F; Barletta A; D'Angelo M; Giammaria A; Parzanese I; Rizza V; Iaria G; Famulari A
    Transplant Proc; 2005; 37(6):2529-31. PubMed ID: 16182735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Early de novo neoplasia after renal transplantation].
    Veroux P; Veroux M; Puliatti C; Amodeo C; Macarone M; Cappello D; Caglià P
    Tumori; 2003; 89(4 Suppl):301-4. PubMed ID: 12903627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the incidence of de novo solid malignancies after heart transplantation to that in the general population.
    Kellerman L; Neugut A; Burke B; Mancini D
    Am J Cardiol; 2009 Feb; 103(4):562-6. PubMed ID: 19195521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.